Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

COLOURTEST

Financiado

Cerrado

The development evaluation and commercialisation of an early years test of colo...

The development evaluation and commercialisation of an early years test of colour vision deficiency. Colour vision deficiency (CVD) is a genetic disorder of colour vision that affects 7.4% of European males and 0.4% of European females. Although there are reliable tests for diagnosing CVD in adults and older children, there are o... ver más

31/05/2018

UOS

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

THE UNIVERSITY OF SUSSEX No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-05-31

ERC-PoC-2015: ERC Proof of Concept Grant

I+D

Cerrada hace 10 años

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

UOS

149.65K€ | Lider

CEPSA QUÍMICA,

2.23M€ | Participante

SUSSEX INNOVATION CENTRE MAN...

9.22K€ | Participante

Proyectos interesantes

EURO-GENE-SCAN

Medical Technol...

Data Science

4M€ Cerrado

ARISE

Medical Technol...

Data Science

2M€ Cerrado

PID2020-114083GB-I00

Medical Technol...

Data Science

99K€ Cerrado

TIN2013-46751-R

Medical Technol...

Data Science

169K€ Cerrado

NMD-CHIP

Medical Technol...

Data Science

4M€ Cerrado

NIPD

Medical Technol...

Data Science

3M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 18 meses Fecha Inicio: 2016-11-17
Fecha Fin: 2018-05-31

Líder del proyecto

THE UNIVERSITY OF SUSSEX No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 150K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Colour vision deficiency (CVD) is a genetic disorder of colour vision that affects 7.4% of European males and 0.4% of European females. Although there are reliable tests for diagnosing CVD in adults and older children, there are only a few tests for young children, and fundamental issues with these tests render them unreliable. For example, colours used in the tests are too similar for young children to discriminate given their immature colour vision, tasks are too difficult for them to complete, tests either over- or under-diagnose CVD, or are not widely accessible. Therefore, the current situation is that CVD can be reliably diagnosed only from about 5 years onwards. Earlier diagnosis would enable steps to be taken to ensure CVD children are not disadvantaged in early years education that relies on colour coded schemes and materials. Our goal is to develop, evaluate and bring to market an age-appropriate early years test for CVD. Our research on the ERC funded ‘CATEGORIES’ project is investigating the development of colour perception in over 1400 infants and toddlers. This extensive testing has given us specialist insight into the exact colours that are appropriate for an early years test for CVD. We have also developed age-appropriate tasks that measure young children’s responses to colour in a reliable and efficient manner. In the current project we propose to develop an early years CVD test in the form of an app. The test will use the colours that we have defined and the tasks that we have developed, and we aim for it to provide an accurate CVD diagnosis. The project will take the test to proof of concept and will establish the scientific validity, technical feasibility and commercialisation process. We aim that the test will be the ‘gold standard’ for educators, clinicians, scientists and parents. This will ensure that CVD can be detected earlier than is currently the case, bringing important and tangible benefits for education, clinical practice and research.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores